Answers are grounded in this paper and cite their sources.
We conclude that BoNT is safe and effective in the long-term treatment of patients with CD. Additional studies are needed to further explore patients real-life experiences and perspectives to better understand the long-term outcomes and reasons for discontinuation of treatment.
No takes yet. Share an insight, caveat, or question.
Marsili et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: